PT-141 (bremelanotide), a synthetic melanocortin-receptor agonist, combined with oxytocin, the nonapeptide hormone studied for social and neuroendocrine signaling — in a single nasal-spray format. Each compound carries its own independent research record. The combined formulation doesn't: no study has tested it together, and its exact composition hasn't been independently verified by a batch-specific certificate of analysis.
HPLC certified
Independent analysis
Highest standard
Full traceability
HCG and LH bind the exact same receptor — yet research shows they send measurably different signals once they do. Here's what's actually established about HCG's structure, mechanism, and the FDA's position on HCG weight-loss claims.
No peer-reviewed human study of IGF-1 LR3 exists — a 2026 literature review placed it in its lowest evidence tier. Here's what the cell and animal research actually shows, and where it stops.
BPC-157 sits in a different WADA category than TB-500 or ipamorelin — and that difference actually matters if you're trying to understand the rules. Here's the 2026 list, compound by compound, with the official source for each.
